Keywords:
Gastrointestinal tract, Oncology, Pancreas, Cone beam CT, Radiation therapy / Oncology, Stereotactic radiotherapy, Cancer, Image guided radiotherapy, Toxicity
Authors:
W. S. Soon1, S. Kwok2, Y. Y. Lee2; 1Cairns, QLD/AU, 2Woolloongabba, Brisbane, QLD/AU
DOI:
10.26044/ranzcr2021/R-0463
References
1. Hammel P, Huguet F, Van Laethem J, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advance pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA 2016; 315(17): 1844-1853.
2. Petrelli F, Comito T, Ghidini A. et al. Stereotactic body radiation therapy for locally advanced pancreatic cancer: A systemic review and pooled analysis of 19 trials. International Journal of Radiation Oncology, Biology, Physics 2017; 97:313–322.
3. Oar A, Lee M, Le H, Hruby G, Dalfsen R, Pryor D, et al. Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT). Pract Radiat Oncol. 2020;10(3):e136-e46.
4. Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, et al. Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief. J Pain Res. 2018;11:2169-78.